Abstract is: Relapse prevention (RP) is a cognitive-behavioral approach to relapse with the goal of identifying and preventing high-risk situations such as unhealthy substance use, obsessive-compulsive behavior, sexual offending, obesity, and depression. It is an important component in the treatment process for alcohol use disorder, or alcohol dependence.
| prevention | Q1717246 |
| P646 | Freebase ID | /m/04gj2zd |
| P1149 | Library of Congress Classification | RC489.R44 |
| P6366 | Microsoft Academic ID | 2781089641 |
| P10283 | OpenAlex ID | C2781089641 |
| P1269 | facet of | addiction | Q12029 |
| Q90000519 | 'Mind the gaps': the accessibility and implementation of an effective depression relapse prevention programme in UK NHS services: learning from mindfulness-based cognitive therapy through a mixed-methods study |
| Q44328541 | 1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial |
| Q60450342 | A Cognitive Behavioral Road Map for Relapse Prevention in Depression |
| Q49920026 | A Pilot Randomized Controlled Trial of a Phone-based Intervention for Smoking Cessation and Relapse Prevention in the Postpartum Period |
| Q33451758 | A Preliminary Investigation of a Relapse Prevention Mobile Application to Maintain Smoking Abstinence Among Individuals With Posttraumatic Stress Disorder |
| Q48695223 | A bibliotherapy approach to relapse prevention in individuals with panic attacks |
| Q37154178 | A cognitive-social learning approach to relapse: pharmacotherapy and relapse prevention counselling |
| Q51706521 | A comparative trial of psychotherapies for ambulatory cocaine abusers: relapse prevention and interpersonal psychotherapy. |
| Q46164306 | A continuous responder analysis from a long-term trial of duloxetine treatment for generalized anxiety disorder: implications for the randomized withdrawal relapse prevention study design |
| Q60603084 | A double-blind randomized placebo-controlled study of relapse prevention in remitted first-episode psychosis patients following one year of maintenance therapy |
| Q48530486 | A focus group analysis of relapse prevention strategies for persons with substance use and mental disorders |
| Q51919653 | A form of relapse prevention for men in a high security hospital. |
| Q102377802 | A historical review of placebo-controlled, relapse prevention trials in schizophrenia: The loss of clinical equipoise |
| Q64265467 | A multisite randomized controlled trial of Seeking Safety vs. Relapse Prevention Training for women with co-occurring posttraumatic stress disorder and substance use disorders |
| Q46605304 | A neuroendocrinological hypothesis on gender effects of naltrexone in relapse prevention treatment |
| Q60603212 | A next-generation social media-based relapse prevention intervention for youth depression: Qualitative data on user experience outcomes for social networking, safety, and clinical benefit |
| Q89709762 | A novel study design for investigating relapse prevention in major depressive disorder: Preliminary data from the open-label period of a phase 4 vortioxetine study |
| Q80339038 | A nurse managed smoking cessation and relapse prevention programme did not reduce smoking rates at 12 months beyond rates achieved by usual care in women with cardiovascular disease |
| Q35041083 | A pilot assessment of relapse prevention for heroin addicts in a Chinese rehabilitation center |
| Q102213897 | A pilot study of mindfulness-based relapse prevention for compulsive sexual behaviour disorder |
| Q38641631 | A placebo controlled trial for an NMO relapse prevention treatment: Ethical considerations |
| Q46872780 | A preliminary study on outpatient relapse prevention program for methamphetamine dependent patients: Serigaya Methamphetamine Relapse Prevention Program (SMARPP) |
| Q73535866 | A program for relapse prevention in schizophrenia: a controlled study |
| Q68560027 | A proposed model of relapse prevention for adolescents who abuse alcohol |
| Q46518072 | A randomised trial of early warning signs relapse prevention training in the treatment of alcohol dependence |
| Q37278225 | A randomized clinical trial of a palmtop computer-delivered treatment for smoking relapse prevention among women |
| Q34531152 | A randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: outcome of the first year |
| Q38382823 | A randomized controlled trial of relapse prevention therapy for first-episode psychosis patients |
| Q36621041 | A randomized controlled trial of relapse prevention therapy for first-episode psychosis patients: outcome at 30-month follow-up |
| Q91647532 | A randomized trial of low-dose gabapentin for post hospitalization relapse prevention in a Thai clinical sample of alcohol dependence |
| Q73570658 | A randomized trial of relapse prevention of depression in primary care |
| Q46481081 | A randomized, controlled trial of omega-3 fatty acids plus an antioxidant for relapse prevention after antipsychotic discontinuation in first-episode schizophrenia. |
| Q77793806 | A relapse prevention group for patients with bipolar and substance use disorders |
| Q47233497 | A sequential multiple assignment randomized trial for cocaine cessation and relapse prevention: Tailoring treatment to the individual. |
| Q44316535 | A stepped care relapse prevention program for depression in older people: a randomized controlled trial |
| Q37720035 | A systematic review of relapse measurement in randomized controlled trials of relapse prevention in first-episode psychosis |
| Q37775077 | A systematic review of the effectiveness of smoking relapse prevention interventions for abstinent smokers. |
| Q79967264 | A trial of a relapse prevention strategy in women with bulimia nervosa who respond to cognitive-behavior therapy |
| Q52274949 | A trial of relapse prevention with severely dependent male problem drinkers. |
| Q37621846 | A two-phased screening paradigm for evaluating candidate medications for cocaine cessation or relapse prevention: modafinil, levodopa-carbidopa, naltrexone. |
| Q45785918 | AB046. The evaluation of therapeutic efficiency of relapse prevention of alternating bladder perfusion with GEM and THP after TURBT of superficial bladder cancer. |
| Q73728321 | Acamprosate and relapse prevention in the treatment of alcohol dependence: a placebo-controlled study |
| Q36839350 | Acamprosate: a new pharmacotherapeutic approach to relapse prevention in alcoholism--preliminary data |
| Q35264397 | Acceptability and Cultural Appropriateness of Self-Help Booklets for Relapse Prevention in Puerto Rico. |
| Q38599859 | Acceptability of an Opioid Relapse Prevention Text-message Intervention for Emergency Department Patients |
| Q43716779 | Acceptance of pharmacotherapy for relapse prevention by chronic alcoholics |
| Q33678223 | Accessibility and implementation in UK services of an effective depression relapse prevention programme - mindfulness-based cognitive therapy (MBCT): ASPIRE study protocol |
| Q95512850 | Accessibility and implementation in the UK NHS services of an effective depression relapse prevention programme: learning from mindfulness-based cognitive therapy through a mixed-methods study |
| Q42994574 | Acetyl-L-carnitine for alcohol craving and relapse prevention in anhedonic alcoholics: a randomized, double-blind, placebo-controlled pilot trial. |
| Q63501817 | Adaptation of mindfulness-based stress reduction program for addiction relapse prevention |
| Q95589940 | Addiction Relapse Prevention |
| Q52277196 | Addiction relapse prevention in solid-organ transplantation. |
| Q40241485 | Adherence to the principles of Motivational Interviewing, clients' characteristics and behavior outcome in a smoking cessation and relapse prevention trial in women postpartum. |
| Q51947430 | Adjunctive cognitive therapy is more effective, but more costly, than standard clinical management for relapse prevention in depression. |
| Q41271121 | Adversity-induced relapse of fear: neural mechanisms and implications for relapse prevention from a study on experimentally induced return-of-fear following fear conditioning and extinction |
| Q45104982 | Alcoholics anonymous and relapse prevention as maintenance strategies after conjoint behavioral alcohol treatment for men: 18-month outcomes |
| Q36898885 | An Open Trial of Relapse Prevention Therapy for Smokers With Schizophrenia |
| Q92736848 | An Outcome Study of the CASA-CHESS Smartphone Relapse Prevention Tool for Latinx Spanish-Speakers with Substance Use Disorders |
| Q35624184 | An analysis of relapse prevention factors and their ability to predict sustained abstinence following treatment completion |
| Q52219537 | An evaluation of a multicomponent treatment program involving scheduled smoking and relapse prevention procedures: initial findings. |
| Q44857879 | An evaluation of the 'Coping with Depression Course' for relapse prevention with unipolar depressed patients |
| Q35578350 | An evaluation of videotaped vignettes for smoking cessation and relapse prevention during pregnancy: the very important pregnant smokers (VIPS) program |
| Q47694594 | An examination of the process of relapse prevention therapy designed to aid smoking cessation. |
| Q70916724 | An instrument for measuring coping behaviours in hospitalized alcoholics: implications for relapse prevention treatment |
| Q79191816 | An integrated relapse prevention and relationship safety intervention for women on methadone: testing short-term effects on intimate partner violence and substance use |
| Q35045776 | An observational study of the Korean proactive quitline service for smoking cessation and relapse prevention |
| Q92241037 | An open trial of rolling admission mindfulness-based relapse prevention (Rolling MBRP): feasibility, acceptability, dose-response relations, and mechanisms |
| Q37248330 | Analysis of health-related quality of life and costs based on a randomised clinical trial of escitalopram for relapse prevention in patients with generalised social anxiety disorder |
| Q44935327 | Analyzing diaries for analytical relapse prevention using natural induction: a method and preliminary results |
| Q38382530 | Antagonist Models for Relapse Prevention and Reducing HIV Risk |
| Q36213564 | Anticraving medications for relapse prevention: a possible new class of psychoactive medications |
| Q85013374 | Antipsychotic drugs for relapse prevention in schizophrenia |
| Q28266069 | Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis |
| Q37942671 | Applications of relapse prevention with moderation goals |
| Q48555260 | Approach versus avoidance goals in relapse prevention with sexual offenders |
| Q92998281 | Are Placebo-Controlled, Relapse Prevention Trials in Schizophrenia Research Still Necessary or Ethical? |
| Q35995252 | Aripiprazole for relapse prevention and craving in alcohol use disorder: current evidence and future perspectives |
| Q51899284 | Aripiprazole for relapse prevention and craving in alcohol-dependent subjects: results from a pilot study. |
| Q44859003 | Aripiprazole is effective for relapse prevention in people with chronic stable schizophrenia |
| Q37742289 | Assessing Feasibility and Acceptability of Web-Based Enhanced Relapse Prevention for Bipolar Disorder (ERPonline): A Randomized Controlled Trial |
| Q43061532 | Assessing informed consent in an opioid relapse prevention study with adults under current or recent criminal justice supervision |
| Q37357172 | Assessment, treatment, and relapse prevention: male hypoactive sexual desire disorder |
| Q61772878 | Assisting relapse prevention in OCD using a novel mobile app–based intervention: A case report |
| Q45259850 | Atomoxetine safety and efficacy in children with attention deficit/hyperactivity disorder (ADHD): initial phase of 10-week treatment in a relapse prevention study with a Spanish sample |
| Q35583885 | Baclofen as relapse prevention in the treatment of Gamma- Hydroxybutyrate (GHB) dependence: an open label study |
| Q47716601 | Baclofen as relapse prevention in the treatment of gamma-hydroxybutyrate dependence: a case series |
| Q45336369 | Batter up! Relapse prevention for homeless veteran substance abusers via softball team participation |
| Q72683530 | Behavioral marital therapy with and without additional couples relapse prevention sessions for alcoholics and their wives |
| Q44535518 | Behavioral relapse prevention strategies in smoking cessation |
| Q44092336 | Brief group psychotherapy in relapse prevention for alcohol dependent patients |
| Q57812097 | Brief intervention on Smoking, Nutrition, Alcohol and Physical (SNAP) inactivity for smoking relapse prevention after release from smoke-free prisons: a study protocol for a multicentre, investigator-blinded, randomised controlled trial |
| Q45105820 | Bupropion SR for relapse prevention: a "slips-allowed" analysis. |
| Q44109630 | Bupropion for pharmacologic relapse prevention to smoking: predictors of outcome |
| Q34043725 | Can craving be modeled in animals? The relapse prevention perspective |
| Q37913565 | Central nervous system relapse prevention in 1165 standard-risk children with acute lymphoblastic leukemia in five BFM trials. |
| Q47395922 | Challenges in preventing relapse in major depression. Report of a National Institute of Mental Health Workshop on state of the science of relapse prevention in major depression |
| Q58146764 | Challenges to relapse prevention: Psychiatric care of Indigenous in-patients |
| Q50001362 | Characteristics of Romanian women who enrolled in a postpartum tobacco smoking relapse prevention trial |
| Q45346904 | Characterizing relapse prevention in bipolar disorder with adjunctive ziprasidone: clinical and methodological implications |
| Q41677316 | Citalopram in doses of 20-60 mg is effective in depression relapse prevention: a placebo-controlled 6 month study. |
| Q64236201 | Clinical evaluation of deep brain stimulation of nucleus accumbens/anterior limb of internal capsule for opioid relapse prevention: protocol of a multicentre, prospective and double-blinded study |
| Q98200407 | Clinical outcomes from the texting for relapse prevention (T4RP) in schizophrenia and schizoaffective disorder study |
| Q42856601 | Clinical predictors of outcome from an Australian pharmacological relapse prevention trial |
| Q58107832 | Cognitive Restructuring as a Relapse Prevention Strategy |
| Q58430030 | Cognitive Therapy for Bipolar Illness—A Pilot Study of Relapse Prevention |
| Q60635777 | Cognitive behavior therapy and relapse prevention for depression |
| Q99556492 | Cognitive remediation following electroconvulsive therapy in patients with treatment resistant depression: randomized controlled trail of an intervention for relapse prevention - study protocol |
| Q33996979 | Cognitive therapy in relapse prevention in depression |
| Q53538849 | Cognitive--behavioural therapy and family intervention for relapse prevention and symptom reduction in psychosis: randomised controlled trial. |
| Q74534099 | Cognitive-behavioral treatment for depression: relapse prevention |
| Q45025677 | Combination treatment with SSRI and cognitive behavior therapy for relapse prevention of alcohol-dependent men. Results of a randomized, controlled multicenter therapeutic study |
| Q45112275 | Combination treatment with nefazodone and cognitive-behavioral therapy for relapse prevention in alcohol-dependent men: a randomized controlled study. |
| Q50629569 | Community-based relapse prevention for opiate dependents: a randomized community controlled trial. |
| Q40261674 | Comparative cost-effectiveness of 11 oral antipsychotics for relapse prevention in schizophrenia within Singapore using effectiveness estimates from a network meta-analysis. |
| Q44351156 | Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial |
| Q52317827 | Comparing Effectiveness of Mindfulness-Based Relapse Prevention with Treatment as Usual on Impulsivity and Relapse for Methadone-Treated Patients: A Randomized Clinical Trial. |
| Q44268856 | Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study |
| Q46176382 | Comparison of Injectable and Oral Antipsychotics in Relapse Rates in a Pragmatic 30-Month Schizophrenia Relapse Prevention Study |
| Q96819158 | Comparison of Relapse Prevention with 3 Different Paliperidone Formulations in Patients with Schizophrenia Continuing versus Discontinuing Active Antipsychotic Treatment: A Post-Hoc Analysis of 3 Similarly Designed Randomized Studies |
| Q44098617 | Compliance, quality assurance and standards for relapse prevention in schizophrenia. |
| Q72451507 | Continuation ECT: relapse prevention in affective disorders |
| Q51927590 | Continuation electroconvulsive therapy for relapse prevention in middle-aged and elderly patients with intractable catatonic schizophrenia. |
| Q34587351 | Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE) |
| Q48069933 | Continued Effectiveness of Relapse Prevention Cognitive-Behavioral Therapy Following Fluoxetine Treatment in Youth With Major Depressive Disorder |
| Q60707943 | Controlled trial of hypnotherapy in relapse prevention of duodenal ulceration |
| Q90979398 | Controlling the laxative abuse of anorexia nervosa patients with the Serigaya Methamphetamine Relapse Prevention Program workbook: a case report |
| Q52316802 | Corrigendum to "Mindfulness-based relapse prevention for substance craving" [Addictive Behaviors 38 (2013) 1563-1571]. |
| Q81172972 | Cost-effectiveness analysis of a complementary health intervention: the case of smoking relapse prevention |
| Q50794265 | Cost-effectiveness analysis of schizophrenia relapse prevention : an economic evaluation of the ZEUS (Ziprasidone-Extended-Use-In-Schizophrenia) study in Spain. |
| Q46729834 | Cost-effectiveness of a psychoeducational relapse prevention program for depression in primary care |
| Q37416862 | Cost-effectiveness of motivational interviewing for smoking cessation and relapse prevention among low-income pregnant women: a randomized controlled trial |
| Q50492053 | Counseling Women on Smoking Relapse Prevention During Postpartum. |
| Q42679948 | Couples relapse prevention sessions after behavioral marital therapy for male alcoholics: outcomes during the three years after starting treatment. |
| Q38000460 | Cue exposure and relapse prevention in the treatment of addictive behaviors |
| Q52173159 | Cue exposure treatment for smoking relapse prevention: a controlled clinical trial. |
| Q38032164 | Cue-exposure interventions for alcohol relapse prevention: need for a memory modification component |
| Q36325788 | Cultural Acceptability of a Smoking Relapse Prevention Intervention for Pregnant Women in Puerto Rico: Providers' Feedback. |
| Q47342553 | Culture and social class as intervening variables in relapse prevention with chemically dependent women |
| Q31140450 | Data management and design issues in an unmasked randomized trial of electroconvulsive therapy for relapse prevention of severe depression: the consortium for research in electroconvulsive therapy trial |
| Q91646287 | Decision-Making Measured by the Iowa Gambling Task in Patients with Alcohol Use Disorders Choosing Harm Reduction versus Relapse Prevention Program |
| Q91875278 | Decreases in the Late Positive Potential to Alcohol Images Among Alcohol Treatment Seekers Following Mindfulness-Based Relapse Prevention |
| Q40452564 | Depot neuroleptics in relapse prevention: advantages and disadvantages. |
| Q35760372 | Depression, craving, and substance use following a randomized trial of mindfulness-based relapse prevention |
| Q92895291 | Depressive Symptoms Assessed Near the End of Pregnancy Predict Differential Response to Postpartum Smoking Relapse Prevention Intervention |
| Q60604241 | Descriptive analyses of the aripiprazole arm in the risperidone long-acting injectable versus quetiapine relapse prevention trial (ConstaTRE) |
| Q51759609 | Desipramine treatment for relapse prevention in cocaine dependence. |
| Q90017828 | Developing Texting for Relapse Prevention: A Scalable mHealth Program for People With Schizophrenia and Schizoaffective Disorder |
| Q30979113 | Differences in Longer-Term Smoking Abstinence After Treatment by Specialist or Nonspecialist Advisors: Secondary Analysis of Data From a Relapse Prevention Trial |
| Q36169974 | Distribution of smoking relapse prevention materials in the Hispanic community: lessons learned. |
| Q73508513 | Divalproex sodium for alcohol withdrawal and relapse prevention: a case report |
| Q43647627 | Diversity in relapse prevention needs: gender and race comparisons among substance abuse treatment patients |
| Q38731213 | Do Psychiatric Disorders or Measures of Distress Moderate Response to Postpartum Relapse Prevention Interventions? |
| Q48130001 | Do antipsychotic drugs lose their efficacy for relapse prevention over time? |
| Q34589584 | Does a home treatment acute relapse prevention strategy reduce admissions for people with mania in bipolar affective disorder? |
| Q52290468 | Does providing extended relapse prevention bibliotherapy to problem gamblers improve outcome? |
| Q52193183 | Does using relapse prevention increase the efficacy of a program for smoking cessation?: An empirical study. |
| Q81668831 | Drug-free relapse prevention |
| Q46762261 | Drugs for relapse prevention of alcoholism: ten years of progress |
| Q46535910 | Duloxetine treatment for relapse prevention in adults with generalized anxiety disorder: a double-blind placebo-controlled trial |
| Q51930956 | Duration of relapse prevention after cognitive therapy in residual depression: follow-up of controlled trial. |
| Q51899337 | Economic evaluation of relapse prevention for substance users: treatment settings and health care policy. |
| Q30489771 | Economic evaluations of smoking cessation and relapse prevention programs for pregnant women: a systematic review |
| Q96763943 | Effect of Mindfulness-Based Relapse Prevention on Impulsivity Trajectories Among Young Adults in Residential Substance Use Disorder Treatment |
| Q89842946 | Effect of a web-based relapse prevention program on abstinence among Japanese drug users: A pilot randomized controlled trial |
| Q97596761 | Effect of holistic relapse prevention intervention among individuals with alcohol dependence: a prospective study at a mental health care setting in India |
| Q79331412 | Effect on disability outcomes of a depression relapse prevention program |
| Q93264478 | Effectiveness evaluation of Serigaya Methamphetamine Relapse Prevention Program in drug addiction rehabilitation center |
| Q58108171 | Effectiveness of Broad Spectrum Approaches to Relapse Prevention in Severe Alcoholism: |
| Q87349941 | Effectiveness of Information Technology Aided Relapse Prevention Programme in Schizophrenia excluding the effect of user adherence: a randomized controlled trial |
| Q59416922 | Effectiveness of Mindfulness-Based Relapse Prevention for Co-occurring Substance Use and Depression Disorders |
| Q90722539 | Effectiveness of Mindfulness-based Relapse Prevention Program as an Adjunct to the Standard Treatment for Smoking: A Pragmatic Design Pilot Study |
| Q91532696 | Effectiveness of Mindfulness-based Relapse Prevention on Quality of Life and Craving in Methadone-treated Patients: A Randomized Clinical Trial |
| Q35639242 | Effectiveness of Relapse Prevention Cognitive-Behavioral Model in Opioid-Dependent Patients Participating in the Methadone Maintenance Treatment in Iran |
| Q89928902 | Effectiveness of WhatsApp online group discussion for smoking relapse prevention: protocol for a pragmatic randomized controlled trial |
| Q43215027 | Effectiveness of a psychosocial intervention for relapse prevention in patients with schizophrenia receiving risperidone via long-acting injection |
| Q36015647 | Effectiveness of adding relapse prevention materials to telephone counseling |
| Q37638920 | Effectiveness of complex psycho-educational interventions for smoking relapse prevention: an exploratory meta-analysis. |
| Q86588500 | Effectiveness of lurasidone vs. quetiapine XR for relapse prevention in schizophrenia: a 12-month, double-blind, noninferiority study |
| Q39584561 | Effectiveness of the information technology-aided program of relapse prevention in schizophrenia (ITAREPS): a randomized, controlled, double-blind study. |
| Q34269680 | Effectiveness of two intensive treatment methods for smoking cessation and relapse prevention in patients with coronary heart disease: study protocol and baseline description |
| Q35105586 | Effectiveness, relapse prevention and mechanisms of change of cognitive therapy vs. interpersonal therapy for depression: Study protocol for a randomised controlled trial |
| Q34555874 | Effects of a relapse prevention program on sexual recidivism: final results from California's sex offender treatment and evaluation project (SOTEP). |
| Q52184183 | Effects of a therapeutic camping program on addiction recovery. The Algonquin Haymarket Relapse Prevention Program. |
| Q42675497 | Effects of gender on relapse prevention in smokers treated with bupropion SR. |
| Q71328153 | Effects of nicotine fading and relapse prevention on smoking cessation |
| Q49083062 | Effects of recurrence on the cognitive performance of patients with bipolar I disorder: implications for relapse prevention and treatment adherence. |
| Q70601474 | Effects of social support and relapse prevention training as adjuncts to a televised smoking-cessation intervention |
| Q38414154 | Efficacy and Safety of the 3-Month Formulation of Paliperidone Palmitate vs Placebo for Relapse Prevention of Schizophrenia: A Randomized Clinical Trial |
| Q64966336 | Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial. |
| Q54975358 | Efficacy of Group Cognitive-behavioral Therapy in Maintenance Treatment and Relapse Prevention for Bipolar Adolescents. |
| Q48182426 | Efficacy of Oral Itraconazole in the Treatment and Relapse Prevention of Moderate to Severe Seborrheic Dermatitis: A Randomized, Placebo-Controlled Trial |
| Q45750933 | Efficacy of aripiprazole versus placebo as adjuncts to lithium or valproate in relapse prevention of manic or mixed episodes in bipolar I patients stratified by index manic or mixed episode |
| Q34733358 | Efficacy of bupropion for relapse prevention in smokers with and without a past history of major depression |
| Q34163102 | Efficacy of paroxetine for relapse prevention in social anxiety disorder: a 24-week study |
| Q33713408 | Efficacy of relapse prevention: a meta-analytic review |
| Q34661628 | Enactment of home practice following mindfulness-based relapse prevention and its association with substance-use outcomes. |
| Q51858266 | Enhanced relapse prevention for bipolar disorder by community mental health teams: cluster feasibility randomised trial. |
| Q33271753 | Enhanced relapse prevention for bipolar disorder--ERP trial. A cluster randomised controlled trial to assess the feasibility of training care coordinators to offer enhanced relapse prevention for bipolar disorder |
| Q37102178 | Enhanced relapse prevention for bipolar disorder: a qualitative investigation of value perceived for service users and care coordinators |
| Q60603223 | Enhancing Treatment Fidelity in Psychotherapy Research: Novel Approach to Measure the Components of Cognitive Behavioural Therapy for Relapse Prevention in First-Episode Psychosis |
| Q48395643 | Enhancing regular physical activity and relapse prevention through a 1-day therapeutic patient education workshop: A pilot study |
| Q84862301 | Evaluation of a cognitive behaviourally oriented service for relapse prevention in schizophrenia |
| Q57244643 | Evaluation of an Online Relapse Prevention Program for Bipolar Disorder |
| Q52221263 | Evaluation of relapse prevention and reinforcement interventions to promote exercise adherence in sedentary females. |
| Q63230000 | Evaluation of the Effectiveness of Adolescent Drug Abuse Treatment, Assessment of Risks for Relapse, and Promising Approaches for Relapse Prevention |
| Q30313221 | Evidence-Based Guidelines for the Pharmacologic Management of Methamphetamine Dependence, Relapse Prevention, Chronic Methamphetamine-Related, and Comorbid Psychiatric Disorders in Post-Acute Settings |
| Q46779040 | Examining psychometric properties of distress tolerance and its moderation of mindfulness-based relapse prevention effects on alcohol and other drug use outcomes |
| Q50959859 | Exercise slips in high-risk situations and activity patterns in long-term exercisers: an application of the relapse prevention model. |
| Q104285122 | Exploring the Feasibility of Relapse Prevention Strategies in Interdisciplinary Multimodal Pain Therapy Programs: Qualitative Study |
| Q60767799 | Exposure and response prevention in anxiety disorders: Implications for treatment and relapse prevention in problem drinkers |
| Q34982976 | Extended interactive voice response telephony (IVR) for relapse prevention after smoking cessation using varenicline and IVR: a pilot study |
| Q44788096 | Extended-release venlafaxine in relapse prevention for patients with major depressive disorder |
| Q69606759 | Extending relapse prevention models to couples |
| Q30843923 | Eye movement desensitization and reprocessing therapy versus supportive therapy in affective relapse prevention in bipolar patients with a history of trauma: study protocol for a randomized controlled trial |
| Q58457977 | FLUOXETINE FOR DEPRESSION RELAPSE PREVENTION |
| Q90476886 | Facilitative effects of environmental enrichment for cocaine relapse prevention are dependent on extinction training context and involve increased TrkB signaling in dorsal hippocampus and ventromedial prefrontal cortex |
| Q64925081 | Factors Associated With Successful Medication Discontinuation After a Randomized Clinical Trial of Relapse Prevention in First-Episode Psychosis: A 10-Year Follow-up. |
| Q57450822 | Factors underlying smoking relapse prevention: results of an international Delphi study |
| Q43018239 | Family member involvement in relapse prevention improves alcohol dependence outcomes: a prospective study at an addiction treatment facility in India. |
| Q38376903 | Family outcomes from a randomized control trial of relapse prevention therapy in first-episode psychosis |
| Q41533398 | Feasibility and acceptability of web-based enhanced relapse prevention for bipolar disorder (ERPonline): trial protocol. |
| Q48608904 | Feasibility of implementation of a Dutch smoking cessation and relapse prevention protocol for pregnant women |
| Q34572430 | Feasibility of offering nicotine replacement therapy as a relapse prevention treatment in routine smoking cessation services. |
| Q64973120 | Feasibility, acceptability and preliminary outcomes of a mindfulness-based relapse prevention program in a naturalistic setting among treatment-seeking patients with alcohol use disorder: a prospective observational study. |
| Q46469220 | Feasibility, acceptability, and preliminary outcomes of a mindfulness-based relapse prevention intervention for culturally-diverse, low-income women in substance use disorder treatment. |
| Q91060737 | Field Test of a Dialectical Behavior Therapy Skills Training-Based Intervention for Smoking Cessation and Opioid Relapse Prevention in Methadone Treatment |
| Q44385604 | Fluoxetine in relapse prevention of PTSD. |
| Q45332909 | Fluoxetine in the acute treatment and relapse prevention of combat-related post-traumatic stress disorder: Analysis of the veteran group of a placebo-controlled, randomized clinical trial |
| Q43684680 | Flupenthixol decanoate and relapse prevention in alcoholics: results from a placebo-controlled study |
| Q42595232 | Flupenthixol in relapse prevention in schizophrenics with comorbid alcoholism: results from an open clinical study |
| Q43694540 | Functional recovery results from the risperidone long-acting injectable versus quetiapine relapse prevention trial (ConstaTRE). |
| Q98226106 | Gabapentin for Post-Hospitalization Alcohol Relapse Prevention; Should Gabapentin Be Considered for FDA Approval in the Treatment of Alcohol Use Disorder?: A Case Presentation and Literature Review |
| Q44662400 | Gender-related differences in pharmacological relapse prevention with flupenthixol decanoate in detoxified alcoholics |
| Q51100881 | Group counseling versus individualized relapse prevention aftercare following intensive outpatient treatment for cocaine dependence: initial results. |
| Q56767473 | Haloperidol plasma ‘threshold’ levels for relapse prevention in schizophrenia: a study with haloperidol decanoate |
| Q40176410 | Health-related quality of life (HRQOL) among patients with Generalised Anxiety Disorder: evaluation conducted alongside an escitalopram relapse prevention trial |
| Q93036167 | Home-detoxification and relapse prevention for alcohol dependence in low resource settings: An exploratory study from Goa, India |
| Q95265411 | How effective are antidepressants for depression over the long term? A critical review of relapse prevention trials and the issue of withdrawal confounding |
| Q46064167 | Hypnosis for Smoking Relapse Prevention: A Randomized Trial |
| Q83231883 | ITAREPS relapse prevention in schizophrenia |
| Q62673939 | ITAREPS: Information Technology Aided Relapse Prevention Programme in Schizophrenia |
| Q62838545 | ITAREPS: Information technology aided relapse prevention programme in schizophrenia. A two-year mirror design follow up evaluation |
| Q69651511 | Identification of high-risk situations in a behavioral weight loss program: application of the relapse prevention model |
| Q47577719 | Identifying relapse prevention elements during psychological treatment of depression: Development of an observer-based rating instrument. |
| Q52562530 | Imagine your mood: Study design and protocol of a randomized controlled micro-trial using app-based experience sampling methodology to explore processes of change during relapse prevention interventions for recurrent depression. |
| Q60446857 | Imagine your mood: a step towards personalized relapse prevention in depression |
| Q55556616 | Impact of paliperidone palmitate one-month formulation on relapse prevention in patients with schizophrenia: A post-hoc analysis of a one-year, open-label study stratified by medication adherence. |
| Q40406148 | Implementing a self-management model of relapse prevention for psychosis into routine clinical practice. |
| Q39235341 | Implementing mindfulness-based relapse prevention in diverse populations: challenges and future directions |
| Q48253666 | Improving relapse prevention after successful electroconvulsive therapy for patients with severe depression: completed audit cycle involving 102 full electroconvulsive therapy courses in West Sussex, United kingdom |
| Q34526378 | In vivo purging and relapse prevention following ASCT. |
| Q60446821 | Individual Negative Affective Trajectories Can Be Detected during Different Depressive Relapse Prevention Strategies |
| Q91333255 | Individual gender and group gender composition as predictors of differential benefit from mindfulness-based relapse prevention for substance use disorders |
| Q89722232 | Individual participant data (IPD) meta-analysis of psychological relapse prevention interventions versus control for patients in remission from depression: a protocol |
| Q37241733 | Individualized continuation electroconvulsive therapy and medication as a bridge to relapse prevention after an index course of electroconvulsive therapy in severe mood disorders: a naturalistic 3-year cohort study |
| Q77311508 | Initial maintenance therapy (relapse prevention) and therapy of steroid resistance and dependence |
| Q52130584 | Integrating contingency management with relapse prevention skills: comment on Silverman et al. (2001). |
| Q37139844 | Interactive voice response for relapse prevention following cognitive-behavioral therapy for alcohol use disorders: a pilot study |
| Q44919458 | Intermittent medication, coping and psychotherapy. Interactions in relapse prevention and course modification |
| Q90232708 | Internet- and mobile-based aftercare and relapse prevention in mental disorders: A systematic review and recommendations for future research |
| Q33846074 | Internet-based relapse prevention for anorexia nervosa: nine- month follow-up |
| Q93589489 | Internet-based relapse prevention with therapist support for help-seeking problematic alcohol users: a randomized pilot study |
| Q36667433 | Interoceptive Awareness Is Important for Relapse Prevention: Perceptions of Women Who Received Mindful Body Awareness in Substance Use Disorder Treatment |
| Q63368241 | Interpersonal psychotherapy and relapse prevention for depression |
| Q35636893 | Involving relatives in relapse prevention for bipolar disorder: a multi-perspective qualitative study of value and barriers |
| Q39520101 | Is it time to shift to better characterization of patients in trials assessing novel antidepressants? An example of two relapse prevention studies with agomelatine |
| Q90368728 | Ketamine Versus Midazolam for Depression Relapse Prevention Following Successful Electroconvulsive Therapy: A Randomized Controlled Pilot Trial |
| Q37498103 | Ketamine for depression relapse prevention following electroconvulsive therapy: protocol for a randomised pilot trial (the KEEP-WELL trial). |
| Q91843900 | Lagged effects of substance use on PTSD severity in a randomized controlled trial with modified prolonged exposure and relapse prevention |
| Q84965803 | Lifelong relapse prevention with antipsychotics in schizophrenia |
| Q33879437 | Lifestyle-related disease in Crohn's disease: relapse prevention by a semi-vegetarian diet |
| Q40833689 | Limits of habituation and extinction: implications for relapse prevention programs in addictions. |
| Q40090911 | Lithium and relapse prevention in manic-depressive illness |
| Q38304635 | Lithium for post-electroconvulsive therapy depressive relapse prevention: a consideration of the evidence |
| Q34616063 | Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial |
| Q92863466 | Lofexidine in Combination With Oral Naltrexone for Opioid Use Disorder Relapse Prevention: A Pilot Randomized, Double-Blind, Placebo-Controlled Study |
| Q37341552 | Long-Acting Injectable Risperidone for Relapse Prevention and Control of Breakthrough Symptoms After a Recent First Episode of Schizophrenia. A Randomized Clinical Trial |
| Q91267331 | Long-Term Remission With Cariprazine Treatment in Patients With Schizophrenia: A Post Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Trial |
| Q37042180 | Long-acting injectable paliperidone palmitate versus oral paliperidone extended release: a comparative analysis from two placebo-controlled relapse prevention studies |
| Q37451403 | Long-acting injectable vs oral antipsychotics for relapse prevention in schizophrenia: a meta-analysis of randomized trials |
| Q51936971 | Long-term effects of pharmacotherapy on relapse prevention in alcohol dependence. |
| Q100496333 | Long-term relapse prevention strategies among poly-substance users in Ghana: New insights for clinical practice |
| Q43685689 | Long-term relapse prevention with risperidone in 215 schizophrenic patients |
| Q41899147 | Long-term remission in schizophrenia and schizoaffective disorder: results from the risperidone long-acting injectable versus quetiapine relapse prevention trial (ConstaTRE). |
| Q43065586 | Long-term treatment and relapse prevention of alcohol and benzodiazepine dependence with lamotrigine |
| Q68033817 | Long-term treatment with olsalazine for ulcerative colitis: safety and relapse prevention: a follow-up study |
| Q35065378 | Low dose vs standard dose of antipsychotics for relapse prevention in schizophrenia: meta-analysis |
| Q91322932 | Low-dose anti-inflammatory combinatorial therapy reduced cancer stem cell formation in patient-derived preclinical models for tumour relapse prevention |
| Q90222651 | Low-dose azacitidine for relapse prevention after allogeneic hematopoietic cell transplantation in children with myeloid malignancies |
| Q41056724 | Maintaining Treatment Fidelity of Mindfulness-Based Relapse Prevention Intervention for Alcohol Dependence: A Randomized Controlled Trial Experience |
| Q47757570 | Maintenance repetitive transcranial magnetic stimulation (rTMS) for relapse prevention in with depression: A review |
| Q71432153 | Maintenance strategies for the treatment of obesity: an evaluation of relapse prevention training and posttreatment contact by mail and telephone |
| Q74794987 | Management of withdrawal syndromes and relapse prevention in drug and alcohol dependence |
| Q73343970 | Maternal smoking cessation and relapse prevention during health care visits |
| Q40967758 | Mazindol for relapse prevention to cocaine abuse in methadone-maintained patients |
| Q33506189 | Measuring the costs of outreach motivational interviewing for smoking cessation and relapse prevention among low-income pregnant women |
| Q35951582 | Mechanisms of relapse prevention in schizophrenia |
| Q44413794 | Mesalamine and relapse prevention in Crohn's disease |
| Q37773366 | Meta-analysis of relapse prevention antidepressant trials in depressive disorders |
| Q47439236 | Mindfulness Based Relapse Prevention for Stimulant Dependent Adults: A Pilot Randomized Clinical Trial |
| Q48917566 | Mindfulness and metaphor in relapse prevention: an interview with G. Alan Marlatt. Interview by Deborah K. Shattuck |
| Q33930962 | Mindfulness meditation for alcohol relapse prevention: a feasibility pilot study |
| Q92828765 | Mindfulness practice predicts interleukin-6 responses to a mindfulness-based alcohol relapse prevention intervention |
| Q93053532 | Mindfulness-Based Relapse Prevention and Transcranial Direct Current Stimulation to Reduce Heavy Drinking: A Double-Blind Sham-Controlled Randomized Trial |
| Q60303217 | Mindfulness-Based Relapse Prevention for Alcohol and Substance Use Disorders |
| Q38685688 | Mindfulness-Based Relapse Prevention for Methadone Maintenance: A Feasibility Trial |
| Q58590611 | Mindfulness-Based Relapse Prevention in a Jail Drug Treatment Program |
| Q38654420 | Mindfulness-based Relapse Prevention for Substance Use Disorders: A Systematic Review and Meta-analysis. |
| Q34294144 | Mindfulness-based cognitive therapy for depression: replication and exploration of differential relapse prevention effects |
| Q39644003 | Mindfulness-based cognitive therapy is effective as relapse prevention for patients with recurrent depression in Scandinavian primary health care |
| Q52318205 | Mindfulness-based relapse prevention combined with virtual reality cue exposure for methamphetamine addiction: Study protocol for a randomized controlled trial. |
| Q92534072 | Mindfulness-based relapse prevention for alcohol dependence: Findings from a randomized controlled trial |
| Q36129419 | Mindfulness-based relapse prevention for substance craving |
| Q35760342 | Mindfulness-based relapse prevention for substance use disorders: a pilot efficacy trial |
| Q33719632 | Mindfulness-based relapse prevention with racial and ethnic minority women |
| Q46562275 | Minimal contact treatment for smoking cessation. A placebo controlled trial of nicotine polacrilex and self-directed relapse prevention: initial results of the Stanford Stop Smoking Project |
| Q38835349 | Model of Management (Mo.Ma) for the patient with schizophrenia: crisis control, maintenance, relapse prevention, and recovery with long-acting injectable antipsychotics (LAIs). |
| Q39677800 | Moderated online social therapy for depression relapse prevention in young people: pilot study of a 'next generation' online intervention. |
| Q58260026 | Modified Group Therapy for Substance Abusers:A Psychodynamic Approach to Relapse Prevention |
| Q88502229 | Modified cariprazine relapse prevention clinical trial results |
| Q45958550 | Moment-by-Moment in Women's Recovery: Randomized controlled trial protocol to test the efficacy of a mindfulness-based intervention on treatment retention and relapse prevention among women in residential treatment for substance use disorder. |
| Q37801751 | Monitoring, reentry, and relapse prevention for chemically dependent health care professionals |
| Q33856127 | Motivational Interviewing and Relapse Prevention for DWI: A Pilot Study |
| Q43584572 | Naltrexone and relapse prevention treatment for cocaine-dependent patients |
| Q34435294 | Naltrexone, a relapse prevention maintenance treatment of alcohol dependence: a meta-analysis of randomized controlled trials |
| Q52046265 | Naltrexone, relapse prevention, and supportive therapy with alcoholics: an analysis of patient treatment matching. |
| Q43494712 | Neuro-chemical activation of brain reward meso-limbic circuitry is associated with relapse prevention and drug hunger: a hypothesis |
| Q28335646 | Neurodynamics of relapse prevention: a neuronutrient approach to outpatient DUI offenders |
| Q90310182 | Neurological and psychiatric safety of tafenoquine in Plasmodium vivax relapse prevention: a review |
| Q48371978 | Neuropsychiatric insights in clinical practice: from relapse prevention toward relapse management |
| Q43662295 | New strategies in assessing, treating, and relapse prevention of extramarital affairs |
| Q48134920 | Niccine®, a nicotine vaccine, for relapse prevention: a phase II, randomized, placebo-controlled, multicenter clinical trial |
| Q52913616 | Nicotine gum and self-help behavioral treatment for smoking relapse prevention: results from a trial using population-based recruitment. |
| Q38138081 | Nicotine reduction therapy and relapse prevention for heavy smokers: 3-year follow-up |
| Q47662642 | No Sustainable Effects of an Internet-Based Relapse Prevention Program over 24 Months in Recurrent Depression: Primary Outcomes of a Randomized Controlled Trial |
| Q102209249 | Novel Application for G Protein-Biased Mu Opioid Receptor Agonists in Opioid Relapse Prevention |
| Q103828723 | Nurse-Led Body-Mind-Spirit Based Relapse Prevention Intervention for People With Diagnosis of Alcohol Use Disorder at a Mental Health Care Setting, India: A Pilot Study |
| Q91361357 | OREX-1019: A Novel Treatment of Opioid Use Disorder and Relapse Prevention |
| Q36427635 | Olanzapine - relapse prevention following mania |
| Q44080290 | Olanzapine for cocaine craving and relapse prevention in 2 patients. |
| Q72582543 | Olsalazine versus sulphasalazine for relapse prevention in ulcerative colitis: a multicenter study |
| Q34669624 | Omega-3 fatty acids in first-episode schizophrenia - a randomized controlled study of efficacy and relapse prevention (OFFER): rationale, design, and methods |
| Q39001372 | One year mirror-image study using paliperidone palmitate for relapse prevention of schizophrenia in four university hospitals in Canada. |
| Q53641421 | Operation Stay Quit: evaluation of two smoking relapse prevention strategies for women after involuntary cessation during US Navy recruit training. |
| Q68032780 | Opinion: clinical use of urine testing in relapse prevention |
| Q34653465 | Oral naltrexone as a treatment for relapse prevention in formerly opioid-dependent drug users: a systematic review and economic evaluation |
| Q40285174 | Orexin in Patients with Alcohol Dependence Treated for Relapse Prevention: A Pilot Study. |
| Q51644048 | Outpatient treatment for cocaine abuse: a controlled comparison of relapse prevention and twelve-step approaches. |
| Q60303202 | Overview of Relapse Prevention |
| Q50625496 | Paliperidone depot is not different from haloperidol in relapse prevention of schizophrenia, but different side effects should be considered. |
| Q72662845 | Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression |
| Q35953840 | Pharmacologic management of relapse prevention in addictive disorders |
| Q34272809 | Pharmacological relapse prevention in alcohol dependence: from animal models to clinical trials. |
| Q46398877 | Pharmacological relapse prevention of alcoholism: clinical predictors of outcome |
| Q41001091 | Pharmacotherapy Relapse Prevention in Body Dysmorphic Disorder: A Double-Blind, Placebo-Controlled Trial |
| Q92275747 | Pharmacotherapy for relapse prevention of alcohol use disorder in the Indian setting: A systematic review |
| Q91635676 | Pharmacotherapy in body dysmorphic disorder: relapse prevention and novel treatments |
| Q44341477 | Phase I study of injectable, depot naltrexone for the relapse prevention treatment of opioid dependence |
| Q81468829 | Physicians' and patients' involvement in relapse prevention with antipsychotics in schizophrenia |
| Q46185497 | Placebo controls in clinical trials: concerns about use in relapse prevention studies in schizophrenia |
| Q37459431 | Placebo-controlled study of relapse prevention with risperidone augmentation in older patients with resistant depression |
| Q72565105 | Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics |
| Q67721104 | Placebo-controlled trial of oral 5-ASA in relapse prevention of Crohn's disease |
| Q92352839 | Postorthodontic Relapse Prevention by Administration of Grape Seed (Vitis vinifera) Extract Containing Cyanidine in Rats |
| Q51888262 | Postpartum smoking cessation and relapse prevention intervention: a structural equation modeling application to behavioral and non-behavioral outcomes of a randomized controlled trial. |
| Q93158336 | Pre-emptive azacitidine for relapse prevention in acute myeloid leukaemia |
| Q91341226 | Precision Nutrition and Cancer Relapse Prevention: A Systematic Literature Review |
| Q85893544 | Predictors of Relapse and Dropout During a 12-Week Relapse Prevention Program for Methamphetamine Users |
| Q51903399 | Prescription procedures in medication for relapse prevention after inpatient treatment for alcohol use disorders in Switzerland. |
| Q40359199 | Preventing EPISODE II: relapse prevention in first-episode psychosis |
| Q45261299 | Previous forensic mental examination is a useful marker indicating effective violence relapse prevention among psychotic patients |
| Q34135378 | Process and outcome changes with relapse prevention versus 12-Step aftercare programs for substance abusers |
| Q46637199 | Process evaluation of a nurse-delivered smoking relapse prevention program for new mothers |
| Q41072325 | Prodromal symptoms and relapse prevention in schizophrenia |
| Q48656410 | Progesterone for smoking relapse prevention following delivery: A pilot, randomized, double-blind study |
| Q89886275 | Prophylactic donor lymphocyte infusion for relapse prevention: a meta-analysis |
| Q36406181 | Protocol for a systematic review of telephone delivered psychosocial interventions on relapse prevention, adherence to psychiatric medication and health risk behaviours in adults with a psychotic disorder |
| Q33636809 | Provision of relapse prevention interventions in UK NHS Stop Smoking Services: a survey. |
| Q38984616 | Psychiatrist's adherence: a new factor in relapse prevention of schizophrenia. A randomized controlled study on relapse control through telemedicine system |
| Q38320841 | Psychoeducation for relapse prevention in bipolar disorder: a systematic review of efficacy in randomized controlled trials |
| Q72204065 | Psychoeducational and family therapy in relapse prevention |
| Q91942181 | Psychological Flexibility in Depression Relapse Prevention: Processes of Change and Positive Mental Health in Group-Based ACT for Residual Symptoms |
| Q69973459 | Psychological and pharmacological approaches to smoking relapse prevention |
| Q37558587 | Psychological therapies in bipolar disorder: the effect of illness history on relapse prevention - a systematic review |
| Q92781256 | Psychosocial treatments for relapse prevention in schizophrenia: study protocol for a systematic review and network meta-analysis of randomised evidence |
| Q28259222 | Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group |
| Q34001401 | Quetiapine in relapse prevention in alcoholics suffering from craving and affective symptoms: a case series |
| Q49902928 | Race/ethnicity and racial group composition moderate the effectiveness of mindfulness-based relapse prevention for substance use disorder |
| Q93353994 | Raja yoga meditation and medication-assisted treatment for relapse prevention: A pilot study |
| Q35578254 | Randomised controlled trial of a postpartum relapse prevention intervention |
| Q72154019 | Randomized controlled trial in alcohol relapse prevention: role of atenolol, alcohol craving, and treatment adherence |
| Q46684790 | Randomized controlled trial of relapse prevention and a standard behavioral intervention with adult smokers. |
| Q39221040 | Randomized open-label trial of baclofen for relapse prevention in alcohol dependence |
| Q39235359 | Randomized trial comparing mindfulness-based relapse prevention with relapse prevention for women offenders at a residential addiction treatment center |
| Q48892404 | Randomized trial of Internet-based relapse prevention for partially remitted depression |
| Q36127134 | Rate, timing and predictors of relapse in patients with anorexia nervosa following a relapse prevention program: a cohort study |
| Q52553257 | Rationale, design, and implementation of a clinical trial of a mindfulness-based relapse prevention protocol for the treatment of women with comorbid post traumatic stress disorder and substance use disorder. |
| Q50624418 | Regained control: a phenomenological study of the use of a relapse prevention plan by patients with a bipolar disorder. |
| Q91681729 | Relapse Prevention After Recovery in Patients With Persistent Major Depressive Disorder-An Active Pursuit |
| Q26785433 | Relapse Prevention and the Five Rules of Recovery |
| Q48042803 | Relapse Prevention and the Need for Ongoing Pharmacological Treatment in Body Dysmorphic Disorder |
| Q64077570 | Relapse Prevention by Plant-Based Diet Incorporated into Induction Therapy for Ulcerative Colitis: A Single-Group Trial |
| Q58216803 | Relapse Prevention for Adolescent Substance Abuse |
| Q60303204 | Relapse Prevention for Return of Pathological Worry in CBT-Treated GAD |
| Q58764828 | Relapse Prevention in Alcohol Aftercare: effects on drinking outcome, change process, and aftercare attendance |
| Q38926517 | Relapse Prevention in Alcoholism : Recent Advances and Future Possibilities |
| Q38400866 | Relapse Prevention in Major Depressive Disorder After Successful Acute Electroconvulsive Treatment: a 6-month Double-blind Comparison of Three Fixed Dosages of Escitalopram and a Fixed Dose of Nortriptyline - Lessons from a Failed Randomised Trial o |
| Q54962366 | Relapse Prevention in Schizophrenia and Schizoaffective Disorder with Risperidone Long-Acting Injectable vs Quetiapine: Results of a Long-Term, Open-Label, Randomized Clinical Trial. |
| Q90042612 | Relapse Prevention in Ulcerative Colitis by Plant-Based Diet Through Educational Hospitalization: A Single-Group Trial |
| Q90308891 | Relapse Prevention with Tyrosine Kinase Inhibitors after Allogeneic Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblast Leukemia: A Systematic Review |
| Q91131791 | Relapse prevention (RP) TMS |
| Q35570903 | Relapse prevention after index electroconvulsive therapy in treatment-resistant depression |
| Q46978447 | Relapse prevention among women who stop smoking early in pregnancy: a randomized clinical trial of a self-help intervention |
| Q73574307 | Relapse prevention and antidepressants |
| Q94196622 | Relapse prevention and antidepressants |
| Q34808075 | Relapse prevention and maintaining abstinence in older adults with alcohol-use disorders |
| Q52289683 | Relapse prevention and management. |
| Q79842985 | Relapse prevention and recovery in the treatment of schizophrenia |
| Q50123381 | Relapse prevention and remission attainment in first-episode non-affective psychosis. A randomized, controlled 1-year follow-up comparison of haloperidol, risperidone and olanzapine |
| Q35016038 | Relapse prevention and residual symptoms: a closer analysis of placebo-controlled continuation studies with escitalopram in major depressive disorder, generalized anxiety disorder, social anxiety disorder, and obsessive-compulsive disorder |
| Q91969957 | Relapse prevention and selective serotonin reuptake inhibitor medication in two adolescents with anorexia nervosa |
| Q52263363 | Relapse prevention and smoking cessation. |
| Q48854075 | Relapse prevention and the need for brief social interventions |
| Q62107715 | Relapse prevention as a psychosocial treatment: A review of controlled clinical trials |
| Q44323334 | Relapse prevention as an interventive model for HIV risk reduction in gay and bisexual men. |
| Q71226356 | Relapse prevention by acamprosate. Results from a placebo-controlled study on alcohol dependence |
| Q44776695 | Relapse prevention by citalopram in SAD patients responding to 1 week of light therapy. A placebo-controlled study. |
| Q60445506 | Relapse prevention by means of paroxetine in ECT-treated patients with major depression: a comparison with imipramine and placebo in medium-term continuation therapy |
| Q35184972 | Relapse prevention for addictive behaviors |
| Q35776349 | Relapse prevention for alcohol and drug problems: that was Zen, this is Tao. |
| Q47737995 | Relapse prevention for chemically addicted adolescents in recovery: so which model works? |
| Q52209379 | Relapse prevention for individuals with developmental disabilities, borderline intellectual functioning, or illiteracy. |
| Q24200778 | Relapse prevention for schizophrenia |
| Q36548447 | Relapse prevention for sexual offenders: considerations for the "abstinence violation effect". |
| Q40684960 | Relapse prevention for smoking cessation: review and evaluation of concepts and interventions |
| Q51183218 | Relapse prevention for the adolescent substance abuser. |
| Q44596012 | Relapse prevention group for alcohol dependent patients |
| Q33434873 | Relapse prevention in UK Stop Smoking Services: a qualitative study of health professionals' views and beliefs. |
| Q37805803 | Relapse prevention in UK Stop Smoking Services: current practice, systematic reviews of effectiveness and cost-effectiveness analysis. |
| Q61629051 | Relapse prevention in a national smoking cessation contest: Effects of coping planning |
| Q63361611 | Relapse prevention in abstinent alcoholics by cognitive bias modification: Clinical effects of combining approach bias modification and attention bias modification |
| Q59128329 | Relapse prevention in adults with major depressive disorder treated with vilazodone: a randomized, double-blind, placebo-controlled trial |
| Q43914543 | Relapse prevention in alcohol dependence: acamprosate and naltrexone as a combined pharmacological strategy |
| Q43719680 | Relapse prevention in alcoholics by cigarette smoking? Involvement of nicotinic-dopaminergic mechanisms |
| Q53016724 | Relapse prevention in alcoholics with an anticraving drug treatment: first results of the Berlin Study. |
| Q103812760 | Relapse prevention in ambulant mental health care tailored to patients with schizophrenia and bipolar disorder: A systematic literature review |
| Q52638977 | Relapse prevention in anorexia nervosa: Experiences of patients and parents. |
| Q44824135 | Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone |
| Q34504000 | Relapse prevention in bipolar disorder: a critical review of current guidelines. |
| Q84122041 | Relapse prevention in childhood depression |
| Q38371590 | Relapse prevention in first-episode schizophrenia--maintenance vs intermittent drug treatment with prodrome-based early intervention: results of a randomized controlled trial within the German Research Network on Schizophrenia |
| Q68221362 | Relapse prevention in liver transplant patients treated for liver involvement due to hepatitis B virus |
| Q34120970 | Relapse prevention in major depressive disorder after successful ECT: a literature review and a naturalistic case series |
| Q36063613 | Relapse prevention in major depressive disorder: Mindfulness-based cognitive therapy versus an active control condition |
| Q37428890 | Relapse prevention in manic depressive illness: important and unimportant factors |
| Q96436782 | Relapse prevention in panic disorder with pharmacotherapy: where are we now? |
| Q81333670 | Relapse prevention in patients with bipolar disorder: cognitive therapy outcome after 2 years |
| Q60632940 | Relapse prevention in patients with schizophrenia |
| Q48341378 | Relapse prevention in patients with schizophrenia. |
| Q40560164 | Relapse prevention in patients with schizophrenia: the application of an intervention protocol in nursing practice |
| Q44949283 | Relapse prevention in pediatric patients with ADHD treated with atomoxetine: a randomized, double-blind, placebo-controlled study |
| Q46453454 | Relapse prevention in psychoeducational groups for compulsive crack cocaine smokers |
| Q97891292 | Relapse prevention in recurrent major depressive disorder. A comparison of different treatment options based on clinical experience and a critical review of the literature |
| Q43688789 | Relapse prevention in reflux oesophagitis with regard to Helicobacter pylori status: a double-blind, randomized, multicentre trial to compare the efficacy of pantoprazole versus ranitidine |
| Q60617783 | Relapse prevention in schizophrenia - new therapeutic challenges |
| Q34660553 | Relapse prevention in schizophrenia and schizoaffective disorder with risperidone long-acting injectable vs quetiapine: results of a long-term, open-label, randomized clinical trial |
| Q35165445 | Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials. |
| Q35873789 | Relapse prevention in schizophrenia: a systematic review and meta-analysis of second-generation antipsychotics versus first-generation antipsychotics |
| Q73779384 | Relapse prevention in schizophrenia: attitudes of neurologists-psychiatrists |
| Q62673944 | Relapse prevention in schizophrenia: does group family psychoeducation matter? One-year prospective follow-up field study |
| Q36721923 | Relapse prevention in schizophrenia: evidence from longterm, randomized, double-blind clinical trials. |
| Q51886842 | Relapse prevention in serious and enduring mental illness: a pilot study. |
| Q51968821 | Relapse prevention in serious mental illness. |
| Q68081106 | Relapse prevention in substance misuse: introduction |
| Q96948858 | Relapse prevention in treatment-resistant major depressive disorder with rapid-acting antidepressants |
| Q91100426 | Relapse prevention interventions for smoking cessation |
| Q91536812 | Relapse prevention interventions for smoking cessation |
| Q24200365 | Relapse prevention interventions for smoking cessation |
| Q24241742 | Relapse prevention interventions for smoking cessation |
| Q24244860 | Relapse prevention interventions for smoking cessation |
| Q24250493 | Relapse prevention interventions for smoking cessation |
| Q38714684 | Relapse prevention medications in community treatment for young adults with opioid addiction |
| Q81826170 | Relapse prevention needs more emphasis on interpersonal factors |
| Q43992974 | Relapse prevention of chronic bronchitis |
| Q70365377 | Relapse prevention of duodenal ulcers with trimipramine, cimetidine, or placebo. A double-blind comparison |
| Q51907206 | Relapse prevention of panic disorder in adult outpatient responders to treatment with venlafaxine extended release. |
| Q51190979 | Relapse prevention of sexual aggression. |
| Q44849341 | Relapse prevention of the allergic shoe eczema |
| Q43058705 | Relapse prevention program for drug addicts in center for mental health and welfare |
| Q72811280 | Relapse prevention program for treatment of obsessive-compulsive disorder |
| Q52173436 | Relapse prevention strategies and techniques for inhibited sexual desire. |
| Q48822307 | Relapse prevention strategies and techniques in sex therapy |
| Q32064302 | Relapse prevention strategies and techniques with erectile dysfunction |
| Q44449929 | Relapse prevention strategies for the treatment of cocaine abuse |
| Q48123145 | Relapse prevention study of paliperidone extended-release tablets in Chinese patients with schizophrenia |
| Q52129743 | Relapse prevention training and problem-solving therapy in the long-term management of obesity. |
| Q48753027 | Relapse prevention treatment for cocaine dependence: group vs. individual format |
| Q44990424 | Relapse prevention treatment for liver transplant patients |
| Q69140602 | Relapse prevention versus broad spectrum treatment for smoking cessation: a comparison of efficacy |
| Q86248593 | Relapse prevention via videoconference for anorexia nervosa - findings from the RESTART pilot study |
| Q33964560 | Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review |
| Q34383411 | Relapse prevention with gepirone ER in outpatients with major depression |
| Q36338171 | Relapse prevention with intellectually disabled sexual offenders |
| Q91190920 | Relapse prevention with levomilnacipran ER in adults with major depressive disorder: A multicenter, randomized, double-blind, placebo-controlled study |
| Q74239828 | Relapse prevention with sex offenders: practice, theory and research |
| Q58089185 | Relapse prevention: From radical idea to common practice |
| Q57165307 | Relapse prevention: Using sound to reduce the probability of recidivism and suffering following detoxification |
| Q56790547 | Relapse prevention: a cost-effectiveness analysis of brexpiprazole treatment in adult patients with schizophrenia in the USA |
| Q40673806 | Relapse prevention: an emerging technology for promoting long-term drug abstinence |
| Q52245316 | Relapse prevention: implications for health promotion professionals. |
| Q70965794 | Relapse prevention: introduction and overview of the model |
| Q80421003 | Relapse prevention: still neglected after all these years |
| Q59793854 | Relapse to smoking and health-related quality of life: Secondary analysis of data from a study of smoking relapse prevention |
| Q35811275 | Relative efficacy of mindfulness-based relapse prevention, standard relapse prevention, and treatment as usual for substance use disorders: a randomized clinical trial |
| Q99613917 | Results of a feasibility study of Helpers Stay Quit Training for smoking relapse prevention |
| Q26853000 | Retraining the addicted brain: a review of hypothesized neurobiological mechanisms of mindfulness-based relapse prevention |
| Q90175923 | Retrieval-Extinction and Relapse Prevention: Rewriting Maladaptive Drug Memories? |
| Q37442874 | Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial |
| Q89071994 | Risk of relapse after antidepressant discontinuation in anxiety disorders, obsessive-compulsive disorder, and post-traumatic stress disorder: systematic review and meta-analysis of relapse prevention trials |
| Q40042663 | Risk of relapse after antidepressant discontinuation in anxiety disorders, obsessive-compulsive disorder, and post-traumatic stress disorder: systematic review and meta-analysis of relapse prevention trials. |
| Q48770411 | Ritanserin in relapse prevention in abstinent alcoholics: results from a placebo-controlled double-blind international multicenter trial. Ritanserin in Alcoholism Work Group |
| Q53836197 | SA14. Long-Term Remission With Cariprazine Treatment in Patients With Schizophrenia: A Post Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Trial. |
| Q48034690 | SQ4U - a computer tailored smoking relapse prevention program incorporating planning strategy assignments and multiple feedback time points after the quit-attempt: development and design protocol |
| Q55083376 | SU14. Characteristics Associated With Relapse in Patients With Schizophrenia: Post Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled, Cariprazine Relapse Prevention Trial. |
| Q38740861 | Self-help materials for smoking relapse prevention: a process evaluation of the SHARPISH randomized controlled trial. |
| Q34326281 | Self-hypnosis relapse prevention training with chronic drug/alcohol users: effects on self-esteem, affect, and relapse |
| Q48792378 | Sertraline and relapse prevention training following treatment by very-low-calorie diet: a controlled clinical trial |
| Q81913230 | Seven keys to relapse prevention in schizophrenia |
| Q98200294 | Sex differences in the effects of a combined behavioral and pharmacological treatment strategy for cocaine relapse prevention in an animal model of cue exposure therapy |
| Q43614299 | Short-term combination therapy and long-term relapse prevention in the treatment of severe acne vulgaris. |
| Q45327116 | Situational and affective risk situations of relapse and the quality of implementation intentions in an e-health smoking relapse prevention programme |
| Q104755963 | Smartphone Health Assessment for Relapse Prevention (SHARP): a digital solution toward global mental health |
| Q52914939 | Smoking Relapse Prevention Counseling During Prenatal and Early Postnatal Care |
| Q80364689 | Smoking cessation and relapse prevention among undergraduate students: a pilot demonstration project |
| Q57429784 | Smoking cessation and relapse prevention for postpartum women: Results from a randomized controlled trial at 6, 12, 18 and 24 months |
| Q35830891 | Smoking cessation in pregnancy: a review of postpartum relapse prevention strategies |
| Q48718737 | Smoking relapse prevention during pregnancy. A trial of coordinated advice from physicians and individual counseling |
| Q61875196 | Smoking relapse prevention intervention: a study of postpartum women in Lodz, Poland |
| Q77097233 | Smoking relapse prevention methods for pregnant women: a formative evaluation |
| Q67976948 | Social cognitive theory and relapse prevention: reframing patient compliance |
| Q37426371 | Strategies to Avoid Returning to Smoking (STARTS): a randomized controlled trial of postpartum smoking relapse prevention interventions |
| Q92522819 | Structured Relapse Prevention Program for Chinese Patients in Hong Kong with Comorbidity of Substance Use and Mental Health Disorders: A Feasibility Study |
| Q100745646 | Study protocol for a randomized controlled trial of mindfulness-based relapse prevention for opioid use disorders |
| Q89128928 | Substance use outcomes for mindfulness based relapse prevention are partially mediated by reductions in stress: Results from a randomized trial |
| Q43182533 | Supervised disulfiram in relapse prevention in alcohol-dependent patients suffering from comorbid borderline personality disorder--a case series |
| Q93271123 | Survey design and outcome measures to evaluate the effectiveness of relapse prevention guidance for drug-dependent inmates in-Japan: A review |
| Q43739992 | Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. a randomized, controlled trial. |
| Q68060880 | Symptom monitoring for relapse prevention in schizophrenia |
| Q33306123 | Systematic review of the literature on postpartum care: effectiveness of interventions for smoking relapse prevention, cessation, and reduction in postpartum women |
| Q26741307 | Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date |
| Q34393524 | Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study |
| Q90808104 | Targeting relapse prevention and positive symptom in first-episode schizophrenia using brief cognitive behavioral therapy: A pilot randomized controlled study |
| Q92733157 | The (Lack of) Replication of Self-Reported Mindfulness as a Mechanism of Change in Mindfulness-Based Relapse Prevention for Substance Use Disorders |
| Q52059963 | The ABCs of awareness: a multimodal approach to relapse prevention and intervention--the College Hill Medical Center program. |
| Q50751890 | The Anorexia Relapse Prevention Guidelines in practice: a case report. |
| Q37942666 | The Cenaps model of relapse prevention: basic principles and procedures |
| Q34133355 | The DARE study of relapse prevention in depression: design for a phase 1/2 translational randomised controlled trial involving mindfulness-based cognitive therapy and supported self monitoring. |
| Q60603225 | The EPISODE II trial of cognitive and family therapy for relapse prevention in early psychosis: Rationale and sample characteristics |
| Q40558291 | The Effectiveness of Relapse Prevention with Offenders: A Meta-Analysis |
| Q64950083 | The Efficacy of a Group CBT Relapse Prevention Program for Remitted Anxiety Disorder Patients Who Discontinue Antidepressant Medication: A Randomized Controlled Trial. |
| Q36148051 | The Feasibility and Acceptability of "Arise": An Online Substance Abuse Relapse Prevention Program |
| Q64237491 | The GET READY relapse prevention programme for anxiety and depression: a mixed-methods study protocol |
| Q37722642 | The ICCAM platform study: An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part B: fMRI description |
| Q38977208 | The Imperial College Cambridge Manchester (ICCAM) platform study: An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part A: Study description |
| Q37187281 | The Information Technology Aided Relapse Prevention Programme in Schizophrenia: an extension of a mirror-design follow-up. |
| Q37402783 | The RoadMAP Relapse Prevention Group Counseling Toolkit™: counselor adherence and competence outcomes |
| Q38996051 | The Role of Psychological Distress in Relapse Prevention of Alcohol Addiction. Can High Scores on the SCL-90-R Predict Alcohol Relapse? |
| Q58058101 | The Role of Relapse Prevention and Goal Setting in Training Transfer Enhancement |
| Q71403256 | The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial |
| Q50435494 | The Use of Self-Directed Relapse Prevention Booklets to Assist in Maintaining Abstinence After a 6-Week Group Smoking Cessation Treatment Program: A Randomized Controlled Trial. |
| Q58286552 | The Use of Transcendental Meditation in Relapse Prevention Counseling |
| Q41672786 | The Use of a Structured Assessment Interview as an Intervention to Reduce Dropout Rates in Outpatient Relapse Prevention Groups for “Problem” Drinkers |
| Q47326887 | The compensatory model in weight control: relapse prevention revisited |
| Q36537076 | The current unsatisfactory state of relapse prevention in schizophrenic psychoses--suggestions for improvement |
| Q52687934 | The effect of CBT and its modifications for relapse prevention in major depressive disorder: a systematic review and meta-analysis. |
| Q51812566 | The effectiveness of internet chat groups in relapse prevention after inpatient psychotherapy. |
| Q43246285 | The effects on depression of Internet-administered behavioural activation and physical exercise with treatment rationale and relapse prevention: study protocol for a randomised controlled trial |
| Q50723129 | The good lives model or relapse prevention: what works better in facilitating change? |
| Q52011048 | The impact of managed care systems on relapse prevention and quality of life for patients with schizophrenia. |
| Q52591267 | The impact of social media-based support groups on smoking relapse prevention in Saudi Arabia. |
| Q84018027 | The long-term effects of mindfulness-based cognitive therapy as a relapse prevention treatment for major depressive disorder |
| Q35760332 | The mindfulness-based relapse prevention adherence and competence scale: development, interrater reliability, and validity |
| Q80233907 | The moderating effect of avoidant coping on restrained eaters' risk for disinhibited eating: implications for dietary relapse prevention |
| Q58294493 | The need for relapse prevention strategies in Top End remote indigenous mental health |
| Q48715778 | The pharmacotherapy of relapse prevention using anticonvulsants |
| Q93264466 | The potential of e-Health for treatment and prevention for drug dependence process of development and revision of web-based relapse prevention program "e-SMARPP" |
| Q34062912 | The reinstatement model and relapse prevention: a clinical perspective. |
| Q56959854 | The role of alcohol and drug relapse prevention in the treatment and prevention of HIV disease |
| Q91614923 | The role of relapse prevention for depression in collaborative care: A systematic review |
| Q41472741 | The sequential approach to relapse prevention in unipolar depression |
| Q45284157 | The suspension of an announced trial on relapse prevention in Crohn's ileitis with a 5-ASA formulation in microgranular form |
| Q52233984 | The use of calcium carbimide in relapse prevention counselling: results of a randomized controlled trial |
| Q44070882 | The use of divalproex in alcohol relapse prevention: a pilot study |
| Q36180308 | The use of medication for relapse prevention in substance dependence disorders. |
| Q92585268 | The use of placebo in schizophrenia relapse prevention studies: scientific or ethical debate? |
| Q43626124 | Therapeutic drug monitoring of clozapine in relapse prevention: a five-year prospective study. |
| Q101331928 | Therapeutic success in relapse prevention in alcohol use disorder: the role of treatment motivation and drinking-related treatment goals |
| Q60303209 | Therapist's Guide to Evidence-Based Relapse Prevention |
| Q90223960 | Timing of onset of lithium relapse prevention - how early, how late? |
| Q91676491 | Timing of onset of lithium relapse prevention in bipolar disorder: evidence from randomised trials |
| Q43709026 | Toward an era of relapse prevention in chemical dependency: what can dentistry do to help? |
| Q37576836 | Towards a rehabilitation of methadone maintenance: integration of relapse prevention and aftercare |
| Q36031050 | Towards consensus in the long-term management of relapse prevention in schizophrenia |
| Q51869820 | Training staff in enhanced relapse prevention for bipolar disorder: rates of uptake and measures of skill and confidence. |
| Q43852050 | Transcranial Doppler in smoking relapse prevention strategy. |
| Q45087555 | Treating adult marijuana dependence: a test of the relapse prevention model |
| Q42815454 | Treating drug dependent patients through outpatient group therapy-Serigaya Methamphetamine Relapse Prevention Program (SMARPP) |
| Q34626410 | Treatment and relapse prevention for adolescent substance abuse |
| Q57817504 | Treatment of atopic dermatitis: A comparison of psychological and dermatological approaches to relapse prevention |
| Q44118248 | Treatment of cocaine-alcohol dependence with naltrexone and relapse prevention therapy |
| Q44682728 | Treatment of dual diagnosis patients: a relapse prevention group approach |
| Q53441139 | Triple advantages of injectable long acting second generation antipsychotics: Relapse prevention, neuroprotection, and lower mortality. |
| Q39097463 | Tropomyosin-related kinase B inhibitor has potential for tumor regression and relapse prevention in pulmonary large cell neuroendocrine carcinoma |
| Q62477981 | Twelve-month follow-up of a smoking relapse prevention intervention for postpartum women |
| Q44764267 | Two-year outcome of internet-based relapse prevention for partially remitted depression |
| Q42635659 | Two-year study of relapse prevention by a new education program in schizophrenic patients treated with the same antipsychotic drug |
| Q69923827 | Ulcer healing and relapse prevention by ranitidine in peptic ulcer disease |
| Q91842010 | Understanding Implementation of a Digital Self-Monitoring Intervention for Relapse Prevention in Psychosis: Protocol for a Mixed Method Process Evaluation |
| Q43907494 | Use of acamprosate and different kinds of psychosocial support in relapse prevention of alcoholism. Results from a non-blind, multicentre study |
| Q73067002 | Use of cognitive therapy for relapse prevention in chronic depression. Cost-effectiveness study |
| Q44348126 | Use of disulfiram for alcohol relapse prevention in patients in opioid maintenance treatment |
| Q36274296 | Using WhatsApp and Facebook Online Social Groups for Smoking Relapse Prevention for Recent Quitters: A Pilot Pragmatic Cluster Randomized Controlled Trial. |
| Q38107338 | Using conditioned place preference to identify relapse prevention medications |
| Q96430255 | Using mind control to modify cue-reactivity in AUD: the impact of mindfulness-based relapse prevention on real-time fMRI neurofeedback to modify cue-reactivity in alcohol use disorder: a randomized controlled trial |
| Q27334486 | Virtual reality cue exposure for the relapse prevention of tobacco consumption: a study protocol for a randomized controlled trial |
| Q36485305 | Web-Based Cognitive Behavioral Relapse Prevention Program With Tailored Feedback for People With Methamphetamine and Other Drug Use Problems: Development and Usability Study |
| Q36765696 | Web-based cognitive behavioral relapse prevention program with tailored feedback for people with methamphetamine and other drug use problems: protocol for a multicenter randomized controlled trial in Japan. |
| Q48909185 | Weight change among participants in a large sample minimal contact smoking relapse prevention trial |
| Q86606088 | [A double-blind randomized placebo-controlled study of the efficacy of the combined treatment with naltrexone and guanfacine for relapse prevention in opiate dependence] |
| Q73974545 | [Alcoholism: relapse prevention] |
| Q45925110 | [Development and evaluation of a relapse prevention tool for drug-abusing delinquents incarcerated in a juvenile classification home: a self-teaching workbook for adolescents, the "SMARPP-Jr]. |
| Q62673935 | [Education in schizophrenia: how patients and their relatives assess the relapse prevention programme PREDUKA] |
| Q87991797 | [Effects of a Relapse Prevention Program on Insight, Empowerment and Treatment Adherence in Patients with Schizophrenia] |
| Q95411737 | [Efficacy of the Serigaya Methamphetamine Relapse Prevention Program (SMARPP): for patients with drug use disorder: A study on factors influencing 1-year follow-up outcomes] |
| Q84809850 | [Evaluation of the Relapse Prevention Guidance for drug-dependent inmates: the intervention using self-teach workbook and group therapy in a "Private Finance Initiative" prison --the second report] |
| Q84450458 | [Evaluation of the relapse prevention guidance for drug-dependent inmates: the intervention using self-teach workbook and group therapy in a "private finance initiative" prison--the first report] |
| Q95412663 | [Evaluation of the relapse prevention program for substance abusers called "TAMARPP" at mental health and welfare center] |
| Q82856307 | [Is our clinical practice of antipsychotic relapse prevention in schizophrenia really evidence-based] |
| Q50578727 | [Mindfulness-based-relapse prevention (MBRP): Evaluation of the impact of a group of Mindfulness Therapy in alcohol relapse prevention for alcohol use disorders]. |
| Q79378568 | [Pharmacological relapse prevention in alcohol and tobacco dependence] |
| Q74454080 | [Psychoeducation in schizophrenia relapse prevention] |
| Q52306838 | [Qualitative evaluation of TAMARPP, the relapse prevention program for substance abusers at the Mental Health and Welfare Center]. |
| Q73401191 | [Relapse Prevention Program in German Alcoholics] |
| Q83107845 | [Relapse prevention group therapy for paedophiles: French adaptation] |
| Q45919259 | [Relapse prevention in anorexia nervosa]. |
| Q95501958 | [Relapse prevention in drug addicts] |
| Q52288133 | [Relapse prevention in the treatment of addictive behaviors]. |
| Q50571966 | [Relapse prevention program consisting of coping skills training, cue exposure treatment, and letter therapy for Japanese alcoholic men who relapsed after standard cognitive-behavioral therapy]. |
| Q95622310 | [Response to treatment of patients abusing the "dappou drug" who participated in a group relapse prevention program: a comparison with patients abusing methamphetamine] |
| Q61996764 | [Use of progesterone-releasing intra-uterine system in menhorragia relapse prevention after laparoscopic myomectomy] |
| Q108225652 | “Tougher than ever”: An exploration of relapse prevention strategies among patients recovering from poly-substance use disorders in Ghana |
| Q121097694 | Darashinai otto ja nakute izonsho deshita | depicts | P180 |